🇺🇸 PFE — Pfizer Inc.

Salud Compra
← Volver

Precio actual

30,79 USD

Máx. histórico

61,25

1784 días

Split 1054:1000 del 17/11/2020

Caída desde máximo

-49,73%

Rango 52 semanas

23,62 – 31,06

Variación hoy

+2,63%

Cierre anterior

30,00

Rango de hoy

30,04 – 30,90

Volumen hoy

48.251.619

Peor caída histórica

-69,25%

12/04/1999 → 02/03/2009

Recuperado en 1717 días

Volatilidad anualizada ⓘ

27,33%

Información
Nombre completo
Pfizer Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
75.000
PER ⓘ
41,61 (puede no estar actualizado)
Dividend yield
5,73% (puede no estar actualizado)
Precio objetivo analistas
29,45 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 2 horas
Sobre la empresa

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Dividendos repartidos Total últimos 12 meses: 1,7200 USD · Yield: 5,59%
Fecha de pago Importe por participación
06/05/2015 0,2657 USD
04/02/2015 0,2657 USD
05/11/2014 0,2467 USD
30/07/2014 0,2467 USD
07/05/2014 0,2467 USD
05/02/2014 0,2467 USD
06/11/2013 0,2277 USD
31/07/2013 0,2277 USD
08/05/2013 0,2277 USD
30/01/2013 0,2277 USD
07/11/2012 0,2087 USD
01/08/2012 0,2087 USD
09/05/2012 0,2087 USD
01/02/2012 0,2087 USD
08/11/2011 0,1898 USD
Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2020 1054:1000
01/07/1999 3:1
01/07/1997 2:1
03/07/1995 2:1
01/04/1991 2:1
01/07/1983 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
01/04/1974 0,74 0,75 0,74 0,74 +0,00% 1,00% 900.538
29/03/1974 0,74 0,74 0,73 0,74 +0,00% 1,34% 2.630.784
28/03/1974 0,76 0,76 0,74 0,74 -4,77% 2,28% 1.573.411
27/03/1974 0,79 0,80 0,77 0,78 -1,26% 3,77% 1.532.938
26/03/1974 0,78 0,79 0,78 0,79 +1,27% 1,27% 804.413
25/03/1974 0,78 0,78 0,77 0,78 +0,00% 1,27% 875.242
22/03/1974 0,78 0,78 0,77 0,78 +0,00% 1,27% 1.077.610
21/03/1974 0,78 0,79 0,78 0,78 +0,00% 1,27% 571.690
20/03/1974 0,77 0,78 0,77 0,78 +2,61% 1,29% 571.690
19/03/1974 0,78 0,79 0,76 0,76 -2,54% 3,82% 1.027.018
18/03/1974 0,80 0,80 0,77 0,78 -2,48% 3,72% 1.295.155
15/03/1974 0,81 0,81 0,79 0,80 -0,92% 2,15% 708.288
14/03/1974 0,79 0,82 0,78 0,81 +2,19% 4,69% 2.413.238
13/03/1974 0,78 0,80 0,78 0,79 +2,58% 2,54% 1.578.470
12/03/1974 0,78 0,79 0,77 0,77 -1,27% 2,54% 1.821.312
11/03/1974 0,78 0,79 0,76 0,78 +0,00% 3,82% 1.613.885
08/03/1974 0,77 0,79 0,76 0,78 +1,29% 3,87% 1.563.293
07/03/1974 0,78 0,79 0,77 0,77 -1,27% 2,54% 445.210
06/03/1974 0,79 0,80 0,77 0,78 -1,26% 3,77% 1.796.016
05/03/1974 0,79 0,80 0,79 0,79 +1,27% 1,26% 2.605.488
04/03/1974 0,76 0,78 0,75 0,78 +2,61% 3,92% 500.861
01/03/1974 0,76 0,76 0,75 0,76 +0,00% 1,31% 900.538
28/02/1974 0,77 0,78 0,75 0,76 -1,29% 3,87% 1.118.083
27/02/1974 0,76 0,78 0,76 0,77 +2,64% 2,61% 956.189
26/02/1974 0,76 0,76 0,75 0,75 -2,58% 1,31% 1.264.800
25/02/1974 0,77 0,78 0,76 0,77 +0,00% 2,58% 698.170
22/02/1974 0,75 0,78 0,75 0,77 +2,64% 3,97% 1.254.682
21/02/1974 0,74 0,75 0,73 0,75 +1,00% 2,33% 526.157
20/02/1974 0,73 0,75 0,72 0,74 +1,35% 3,71% 986.544
19/02/1974 0,75 0,77 0,73 0,73 -2,31% 4,96% 3.910.762